Bi-modal (also known as 'prime-boost') immunization takes advantage of the diverse responsesgenerated by immunogens presented in different contexts. These include innate responses to differentadjuvants and vectors, as well as antigen-specific responses resulting from different antigen presentationpathways. In recent years, effort has been focused on generating cell-mediated immunity (CMI) by the use ofnon-replicating viral vectors, such as MVA or replication-defective adenovirus, and DMAvaccines. However,the importance of humoral responses, including broadly reactive neutralizing antibodies and antibody-dependent cellular cytotoxicity (ADCC) activities, has been increasingly recognized. Therefore, it isnecessary to explore prime-boost strategies likely to induce both CMI and humoral responses. An attractivestrategy is exemplified by priming with replication-competent viral vectors (e.g., adenovirus) expressingmultiple HIV antigens, followed by boosting with subunit protein immunogens, as proposed in this ProgramProject. The overall goal of this Core is to provide investigators in Projects 2 and 3 with recombinant subunitproteins, including HIV-1 clade C gp160, SIV Gag-Pol particles, as well as recombinant SIVmac239 Nefprotein.
The specific aims of this Core are:(1) To express, characterize and purify clade C HIV-1 envelope glycoprotein gp160 from recombinantvaccinia viruses;(2) To express, characterize and purify SIVmac239 Gag-Pol particles from recombinant vaccinia viruses;(3) To express, characterize and purify SIVmac239 Nef from recombinant E. coli.
Showing the most recent 10 out of 77 publications